BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A
393 results:

  • 1. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid leukemia.
    Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J
    Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy.
    Broccia G; Carter J; Ozsin-Ozler C; De Matteis S; Cocco P
    Cancer Control; 2023; 30():10732748231202906. PubMed ID: 37877513
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epidemiology of Chronic Lymphocytic leukemia in Sardinia, Italy (1974-2003).
    Broccia G; Carter J; Ozsin-Ozler C; De Matteis S; Cocco P
    Exp Hematol; 2023; 125-126():37-44. PubMed ID: 37567460
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inhibition of MYC translation through targeting of the newly identified PHB-eif4f complex as a therapeutic strategy in CLL.
    Largeot A; Klapp V; Viry E; Gonder S; Fernandez Botana I; Blomme A; Benzarti M; Pierson S; Duculty C; Marttila P; Wierz M; Gargiulo E; Pagano G; An N; El Hachem N; Perez Hernandez D; Chakraborty S; Ysebaert L; François JH; Cortez Clemente S; Berchem G; Efremov DG; Dittmar G; Szpakowska M; Chevigné A; Nazarov PV; Helleday T; Close P; Meiser J; Stamatopoulos B; Désaubry L; Paggetti J; Moussay E
    Blood; 2023 Jun; 141(26):3166-3183. PubMed ID: 37084385
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Systematic Review of Antimicrobial Lock Solutions for Prevention of Bacteremia in Pediatric Patients With Intestinal Failure.
    Gibson B; McNiven C; Sebastianski M; Vandermeer B; Persad R; Robinson JL
    J Pediatr Gastroenterol Nutr; 2023 Apr; 76(4):410-417. PubMed ID: 36730306
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant.
    McDonald A; Dai C; Meng Q; Hageman L; Richman J; Wu J; Francisco L; Ross E; Balas N; Bosworth A; Te HS; Wong FL; Landier W; Salzman D; Bhatia R; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
    JAMA Oncol; 2023 Mar; 9(3):376-385. PubMed ID: 36656600
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood.
    Holmqvist AS; Chen Y; Hageman L; Landier W; Wu J; Francisco LF; Ross ES; Balas NA; Bosworth A; Te HS; Goldman FD; Rosenthal J; Wong FL; Weisdorf DJ; Armenian SH; Bhatia S
    Cancer; 2023 Feb; 129(4):624-633. PubMed ID: 36484292
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. eif4a inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax.
    Fooks K; Galicia-Vazquez G; Gife V; Schcolnik-Cabrera A; Nouhi Z; Poon WWL; Luo V; Rys RN; Aloyz R; Orthwein A; Johnson NA; Hulea L; Mercier FE
    J Exp Clin Cancer Res; 2022 Dec; 41(1):340. PubMed ID: 36482393
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation.
    Thus YJ; De Rooij MFM; Swier N; Beijersbergen RL; Guikema JEJ; Kersten MJ; Eldering E; Pals ST; Kater AP; Spaargaren M
    Haematologica; 2023 Mar; 108(3):797-810. PubMed ID: 36226498
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors.
    Liu L; Vujovic A; Deshpande NP; Sathe S; Anande G; Chen HTT; Xu J; Minden MD; Yeo GW; Unnikrishnan A; Hope KJ; Lu Y
    Nat Commun; 2022 Jul; 13(1):3833. PubMed ID: 35781533
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
    Armenian SH; Chen Y; Hageman L; Wu J; Landier W; Bosworth A; Francisco L; Schlichting E; Bhatia R; Salzman D; Wong FL; Weisdorf DJ; Forman SJ; Arora M; Bhatia S
    J Clin Oncol; 2022 Oct; 40(28):3278-3288. PubMed ID: 35731989
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells.
    Taylor J; Wilmore S; Marriot S; Rogers-Broadway KR; Fell R; Minton AR; Branch T; Ashton-Key M; Coldwell M; Stevenson FK; Forconi F; Steele AJ; Packham G; Yeomans A
    Cell Signal; 2022 Jun; 94():110311. PubMed ID: 35306137
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Transfusion thresholds for guiding red blood cell transfusion.
    Carson JL; Stanworth SJ; Dennis JA; Trivella M; Roubinian N; Fergusson DA; Triulzi D; Dorée C; Hébert PC
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD002042. PubMed ID: 34932836
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cancer risk in individuals with intellectual disability in Sweden: A population-based cohort study.
    Liu Q; Adami HO; Reichenberg A; Kolevzon A; Fang F; Sandin S
    PLoS Med; 2021 Oct; 18(10):e1003840. PubMed ID: 34673770
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster.
    Gershon AA; Gershon MD; Shapiro ED
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S387-S397. PubMed ID: 34590140
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation.
    Sun L; Wang W; Han C; Huang W; Sun Y; Fang K; Zeng Z; Yang Q; Pan Q; Chen T; Luo X; Chen Y
    Mol Cell; 2021 Nov; 81(21):4493-4508.e9. PubMed ID: 34555354
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeted inhibition of eif4a suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
    Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia.
    Wang Y; Zhou W; McReynolds LJ; Katki HA; Griffiths EA; Thota S; Machiela MJ; Yeager M; McCarthy P; Pasquini M; Wang J; Karaesmen E; Rizvi A; Preus L; Tang H; Wang Y; Pooler L; Sheng X; Haiman CA; Van Den Berg D; Spellman SR; Wang T; Kuxhausen M; Chanock SJ; Lee SJ; Hahn TE; Sucheston-Campbell LE; Gadalla SM
    Sci Rep; 2021 Jul; 11(1):15004. PubMed ID: 34294836
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Inhibition of translation initiation factor eif4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML.
    Nishida Y; Zhao R; Heese LE; Akiyama H; Patel S; Jaeger AM; Jacamo RO; Kojima K; Ma MCJ; Ruvolo VR; Chachad D; Devine W; Lindquist S; Davis RE; Porco JA; Whitesell L; Andreeff M; Ishizawa J
    Leukemia; 2021 Sep; 35(9):2469-2481. PubMed ID: 34127794
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 20.